Imran Talat 4
4 · Rani Therapeutics Holdings, Inc. · Filed Mar 24, 2022
Insider Transaction Report
Form 4
Imran Talat
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-22+263,400→ 263,400 totalExercise: $13.21Exp: 2032-03-21→ Class A Common Stock (263,400 underlying) - Award
Class A Common Stock
2022-03-22+86,600→ 98,943 total
Footnotes (2)
- [F1]The shares subject to the restricted stock unit grant vest as follows: 25% of the RSUs shall vest yearly over four years from March 22, 2022.
- [F2]The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022.